DHR Danaher Corp

  1. Stocks
  2. Healthcare
  3. NYSE: DHR

Price (delayed)

$194.98

Market cap

$137.07B

P/E Ratio

34.51

Dividend/share

$1.44

EPS

$5.65

Enterprise value

$159.28B

?
Relative Growth: Rel. Growth: 46
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: 35
Relative Profitability: Rel. Profitability: 74

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to ...

Highlights
DHR's EPS is up by 19% year-on-year and by 9% since the previous quarter
The net income has increased by 17% year-on-year and by 9% since the previous quarter
The quick ratio has declined by 20% since the previous quarter but it has grown by 7% year-on-year
The debt has surged by 53% year-on-year and by 44% since the previous quarter
The gross margin has declined by 2% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.danaher.com
Peers: TMO MMM A EMR

Key stats

What are the main financial stats of DHR

DHR stock price

How has the Danaher stock price performed over time
Intraday
-0.61%
1 week
1.82%
1 month
2.36%
1 year
-1.11%
YTD
-14.83%
QTD
2.36%

Financial performance

How have Danaher's revenue and profit performed over time
Revenue
$25.11B
Gross profit
$14.69B
Operating income
$5.13B
Net income
$4B
Gross margin
58.5%
Net margin
15.9%
The net income has increased by 17% year-on-year and by 9% since the previous quarter
Danaher's operating income has increased by 16% YoY and by 8% from the previous quarter
The net margin is up by 12% year-on-year and by 7% since the previous quarter
DHR's operating margin is up by 11% YoY and by 6% QoQ

Price vs fundamentals

How does DHR's price correlate with its fundamentals

Growth

What is Danaher's growth rate over time

Valuation

What is Danaher stock price valuation
DHR P/E details
P/E
34.51
P/B
2.62
P/S
5.48
EV/EBIT
31.43
EV/EBITDA
20.96
EV/Sales
6.34
DHR's EPS is up by 19% year-on-year and by 9% since the previous quarter
The price to earnings (P/E) is 10% less than the last 4 quarters average of 38.2 and 5% less than the 5-year quarterly average of 36.5
The P/B is 27% less than the 5-year quarterly average of 3.6 and 3% less than the last 4 quarters average of 2.7
DHR's P/S is 24% below its 5-year quarterly average of 7.2 and 3.9% below its last 4 quarters average of 5.7
Danaher's revenue has increased by 4.6% YoY

Efficiency

How efficient is Danaher business performance
Danaher's ROE has increased by 15% YoY and by 8% from the previous quarter
DHR's return on sales is up by 11% year-on-year and by 9% since the previous quarter
DHR's ROA is up by 9% year-on-year and by 4.4% since the previous quarter

Dividends

What is DHR's dividend history
Dividend details
DPS
$1.44
Dividend yield
0.74%
Payout ratio
25.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Danaher financials performed over time
The total assets is 132% greater than the total liabilities
DHR's total liabilities is up by 36% YoY and by 30% QoQ
The quick ratio has declined by 20% since the previous quarter but it has grown by 7% year-on-year
The debt is 49% smaller than the equity
Danaher's debt to equity has soared by 55% YoY and by 46% from the previous quarter
The debt has surged by 53% year-on-year and by 44% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.